Registered entities
NIKANG THERAPEUTICS, INC.
Reg. No. 82-2593817United States
Innovation
58 patent families (8 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 4,014 times.
| Year | Filings |
|---|---|
| 2020 | 6 |
| 2021 | 9 |
| 2022 | 17 |
| 2023 | 16 |
| 2024 | 25 |
| 2025 | 27 |
| 2026 | 3 |
Investor mix
23 investors on record; lead investors include RTW Investments, Lilly Asia Ventures, Casdin Capital, HBM Healthcare Investments.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 11 | 48% |
| Private equity | 4 | 17% |
| Bank & private debt | 1 | 4% |
| Other / undisclosed | 7 | 30% |